Position in FATE
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$769
+$427 QoQ
Shares Held
285
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 156 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hilltop National Bank holds $458,650 across 11 Biotechnology names. FATE ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
2,163 | $152,815 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
303 | $150,508 | |
| 3 | INCY |
Incyte Corp
|
550 | $62,348 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
201 | $48,434 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
116 | $21,724 | |
| 6 | INSM |
INSMED Inc
|
187 | $19,937 | |
| 7 | NVAX |
Novavax Inc
|
208 | $1,959 | |
| 8 | FATE |
Fate Therapeutics Inc
This page
|
285 | $769 |
All Filings in FATE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $769 | 285 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $342 | 285 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $279 | 285 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $359 | 285 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $319 | 285 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $470 | 285 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $997 | 285 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $934 | 285 | Shares | Defined | 2024-07-10 | |
| 2024-03-31 | $2,091 | 285 | Shares | Defined | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||